Literature DB >> 11744905

Correlation of symptoms with location and severity of pelvic organ prolapse.

R M Ellerkmann1, G W Cundiff, C F Melick, M A Nihira, K Leffler, A E Bent.   

Abstract

OBJECTIVE: The purpose of this study was to compare the symptoms that are related to pelvic floor dysfunction with the location and severity of the coexisting prolapse. STUDY
DESIGN: Two hundred thirty-seven consecutive patients with symptomatic pelvic organ prolapse came to Johns Hopkins Medicine during a 24-month period beginning in July 1998 and completed a symptom-specific Likert scale questionnaire that included standardized questions that were compiled from commonly used validated instruments. All questionnaires were completed by the patients before they were seen by a physician. Further evaluation included a standardized physical examination that included the International Continence Society's system for grading uterovaginal prolapse. Symptoms were categorized according to both severity and associated anatomic compartment. Symptoms that were related to urinary and anal incontinence and voiding, defecatory, sexual, and pelvic floor dysfunction were analyzed with respect to location and severity of pelvic organ prolapse with the use of the nonparametric correlation coefficient, Kendall's tau-b.
RESULTS: The mean age of the women was 57.2 years (range, 23-93 years); 109 of the women (46%) had undergone hysterectomy. Overall, stage II was the most common pelvic organ prolapse (51%) that was encountered. In 77 patients (33%), anterior compartment pelvic organ prolapse predominated; 46 patients (19%) demonstrated posterior compartment prolapse, whereas 26 patients (11%) had apical prolapse. In 88 patients (37%), no single location was more severe than another. Voiding dysfunction that was characterized by urinary hesitancy, prolonged or intermittent flow, and a need to change position was associated with the increasing severity of anterior and apical pelvic organ prolapse. Pelvic pressure and discomfort along with visualization of prolapse were strongly associated with worsening stages of pelvic organ prolapse in all compartments. Defecatory dysfunction characterized by incomplete evacuation and digital manipulation was associated with worsening posterior compartment pelvic organ prolapse. Impairment of sexual relations and duration of abstinence were strongly associated with worsening pelvic organ prolapse. An inverse correlation was observed between increasing severity of pelvic organ prolapse and urinary incontinence and enuresis.
CONCLUSION: Women with pelvic organ prolapse experience symptoms that do not necessarily correlate with compartment-specific defects. Increasing severity of pelvic organ prolapse is weakly to moderately associated with several specific symptoms that are related to urinary incontinence and voiding, defecatory, and sexual dysfunction.

Entities:  

Mesh:

Year:  2001        PMID: 11744905     DOI: 10.1067/mob.2001.119078

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  136 in total

1.  Structural position of the posterior vagina and pelvic floor in women with and without posterior vaginal prolapse.

Authors:  Christina Lewicky-Gaupp; Aisha Yousuf; Kindra A Larson; Dee E Fenner; John O L Delancey
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

2.  Validation, reliability, and responsiveness of Prolapse Quality of Life Questionnaire (P-QOL) in a Brazilian population.

Authors:  Andrea Scarlato; Carolina Chaves Cunha Souza; Eliana Suelotto Machado Fonseca; Marair Gracio Ferreira Sartori; Manoel João Batista de Castello Girão; Rodrigo Aquino Castro
Journal:  Int Urogynecol J       Date:  2011-01-28       Impact factor: 2.894

3.  Clinical impact of bowel symptoms in women with pelvic floor disorders.

Authors:  José Ananias Vasconcelos Neto; Camila Teixeira Moreira Vasconcelos; Sthela Maria Murad Regadas; Leonardo Robson Pinheiro Sobreira Bezerra; Kathiane Augusto Lustosa; Sara Arcanjo Lino Karbage
Journal:  Int Urogynecol J       Date:  2017-03-06       Impact factor: 2.894

4.  Sexual function in women following transvaginal mesh procedures for the treatment of pelvic organ prolapse.

Authors:  Ching-Chung Liang; Tsia-Shu Lo; Ling-Hong Tseng; Yi-Hao Lin; Yu-Jr Lin; Shuenn-Dhy Chang
Journal:  Int Urogynecol J       Date:  2012-03-10       Impact factor: 2.894

5.  The effect of posterior colporrhaphy on anorectal function.

Authors:  Anupreet Dua; Stephen Radley; Steven Brown; Swati Jha; Georgina Jones
Journal:  Int Urogynecol J       Date:  2011-11-24       Impact factor: 2.894

Review 6.  Posterior vaginal compartment prolapse and defecatory dysfunction: are they related?

Authors:  Cara L Grimes; Emily S Lukacz
Journal:  Int Urogynecol J       Date:  2012-01-06       Impact factor: 2.894

7.  Anorectal symptoms before and after laparoscopic sacrocolpoperineopexy for pelvic organ prolapse.

Authors:  Rajeev Ramanah; Marcos Ballester; Elisabeth Chereau; Charles Bui; Roman Rouzier; Emile Daraï
Journal:  Int Urogynecol J       Date:  2012-01-19       Impact factor: 2.894

8.  Short-term natural history in women with symptoms indicative of pelvic organ prolapse.

Authors:  Ann Miedel; Marion Ek; Gunilla Tegerstedt; Marianne Mæhle-Schmidt; Olof Nyrén; Margareta Hammarström
Journal:  Int Urogynecol J       Date:  2010-10-20       Impact factor: 2.894

9.  Quantification of vaginal support: are continuous summary scores better than POPQ stage?

Authors:  Linda Brubaker; Matthew D Barber; Ingrid Nygaard; Charlie W Nager; Edward Varner; Joseph Schaffer; Anthony Visco; Susan Meikle; Cathie Spino
Journal:  Am J Obstet Gynecol       Date:  2010-08-21       Impact factor: 8.661

10.  Preoperative tibial mechanical axis orientation and articular surface design influence on the coronal joint line orientation relative to the ground during gait after total knee arthroplasties.

Authors:  Koji Murakami; Satoshi Hamai; Ken Okazaki; Satoru Ikebe; Hidehiko Higaki; Takeshi Shimoto; Yasuharu Nakashima
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-20       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.